Skip to main content
. 2020 Jul 9;44(3):1049–1063. doi: 10.3892/or.2020.7683

Table I.

Association between IL-6 expression and clinicopathological features of the patients with lung adenocarcinoma (N=128).

IL-6 expression

Clinical parameters Lowa, n Highb, n P-value
Sex 0.214
  Male 24 52
  Female 22 30
Age, years 0.691
  <60 23 44
  ≥60 23 38
TNM stage 0.007d
  I 19 17
  II 14 19
  III 13 46
Lymph node metastasis 0.013c
  N0 23 23
  N1/N2/N3 23 59
a

Samples with scores of 0-3 were classified as having low IL-6 expression.

b

Samples with scores of 4-8 were classified as having high IL-6 expression.

c

P<0.05

d

P<0.01 represent a significant difference. IL-6, interleukin 6.